Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Cancer Medicine|September 26, 2023
Risk factors associated with overall survival in patients with multiple myeloma following carfilzomib treatment: A retrospective study from a large claims database in JapanHiromi Hagiwara, Takafumi Nakayama, Hiroya Hashimoto, et al.
International Journal of Medical Sciences|March 29, 2020
Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting DatabasesHiromi Hagiwara, Hidekatsu Fukuta, Takahiro Niimura, et al.
Journal of Cardiology|June 2, 2021
A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims databaseHiromi Hagiwara, Hidekatsu Fukuta, Hiroya Hashimoto, et al.
Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi|May 10, 2026
Colonic transit study in patients with chronic constipation using Japanese-made radiopaque markersTakeshi Kamiya, Eiji Kubota, Keiji Ozeki, et al.
Journal of Clinical Biochemistry and Nutrition|March 5, 2011
Involvement of oxidative stress and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in inflammatory bowel diseaseSatoshi Tanida, Tsutomu Mizoshita, Takashi Mizushima, et al.
Clinical and Experimental Gastroenterology|April 28, 2015
Managing refractory Crohn's disease: challenges and solutionsSatoshi Tanida, Keiji Ozeki, Tsutomu Mizoshita, et al.
Progress in Rehabilitation Medicine|February 18, 2026
Goal Setting According to Level of Mobility Independence in Home-Visit Rehabilitation Using Canadian Occupational Performance MeasureRie Narukawa, Eri Otaka, Kenji Sato, et al.
Case Reports in Gastroenterology|January 24, 2013
Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's DiseaseKeiji Ozeki, Satoshi Tanida, Tsutomu Mizoshita, et al.
Journal of Clinical Medicine Research|December 2, 2014
The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitisSatoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|October 17, 2022
Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapyKoji Nakada, Atsushi Oshio, Nobuyuki Matsuhashi, et al.
Pageof 15